Loading…

Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia

Saved in:

Bibliographic Details
Published in:	Blood 2022-11, Vol.140 (Supplement 1), p.1705-1707
Main Authors:	Marconi, Giovanni, Piciocchi, Alfonso, Audisio, Ernesta, Priolo, Giorgio, Papayannidis, Cristina, Martelli, Maurizio, Paoloni, Francesca, Lemoli, Roberto Massimo, Bocchia, Monica, Lanza, Francesco, Lico, Albana, Ciceri, Fabio, Della Porta, Matteo G., Frigeni, Marco, Giaccone, Luisa, Beltrami, Germana, Borlenghi, Erika, Di Chio, Maria Chiara, Selleri, Carmine, Crea, Enrico, Urbino, Irene, Sartor, Chiara, Minotti, Clara, Guolo, Fabio, La Sala, Edoardo, Nanni, Jacopo, Simonetti, Giorgia, Bochicchio, Maria Teresa, Saglio, Giuseppe, Venditti, Adriano, Vignetti, Marco, Fazi, Paola, Martinelli, Giovanni
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!